SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000886163-14-000014
Filing Date
2014-02-11
Accepted
2014-02-11 08:36:20
Documents
3
Period of Report
2014-02-11
Items
Item 2.02: Results of Operations and Financial Condition
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K ligand-8xkq4earningsrelease.htm 8-K 21745
2 EXHIBIT q42013earningsrelease.htm EX-99.1 459498
3 ligandlogo.jpg GRAPHIC 36525
  Complete submission text file 0000886163-14-000014.txt   533009
Mailing Address 11119 NORTH TORREY PINES ROAD SUITE 200 LA JOLLA CA 92037
Business Address 11119 NORTH TORREY PINES ROAD SUITE 200 LA JOLLA CA 92037 858-550-7500
LIGAND PHARMACEUTICALS INC (Filer) CIK: 0000886163 (see all company filings)

IRS No.: 770160744 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33093 | Film No.: 14591432
SIC: 2834 Pharmaceutical Preparations